JP2024515714A5 - - Google Patents
Info
- Publication number
- JP2024515714A5 JP2024515714A5 JP2023564598A JP2023564598A JP2024515714A5 JP 2024515714 A5 JP2024515714 A5 JP 2024515714A5 JP 2023564598 A JP2023564598 A JP 2023564598A JP 2023564598 A JP2023564598 A JP 2023564598A JP 2024515714 A5 JP2024515714 A5 JP 2024515714A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- patient
- composition according
- eye
- adrenergic antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163178578P | 2021-04-23 | 2021-04-23 | |
| US63/178,578 | 2021-04-23 | ||
| PCT/US2022/025912 WO2022226286A1 (en) | 2021-04-23 | 2022-04-22 | Methods and compositions for treating mydriasis, glaucoma, and other ocular conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515714A JP2024515714A (ja) | 2024-04-10 |
| JP2024515714A5 true JP2024515714A5 (enExample) | 2025-04-30 |
Family
ID=83722635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564598A Pending JP2024515714A (ja) | 2021-04-23 | 2022-04-22 | 散瞳、緑内障、及び他の眼の病態を治療するための方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240216334A1 (enExample) |
| EP (1) | EP4326261A4 (enExample) |
| JP (1) | JP2024515714A (enExample) |
| CN (1) | CN117529316A (enExample) |
| AU (1) | AU2022261123A1 (enExample) |
| CA (1) | CA3216328A1 (enExample) |
| WO (1) | WO2022226286A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3870170T3 (da) | 2018-10-26 | 2026-05-26 | Opus Genetics Inc | Behandling af presbyopi og mydriasis med fentolamin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0724558D0 (en) * | 2007-12-15 | 2008-01-30 | Sharma Anant | Optical correction |
| CA2899342C (en) * | 2013-02-01 | 2021-09-21 | Ocularis Pharma, Llc | Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance |
| JP2022508715A (ja) * | 2018-10-15 | 2022-01-19 | オキュフィア・ファーマ・インコーポレイテッド | 緑内障および関連状態の処置のための方法および組成物 |
| DK3870170T3 (da) * | 2018-10-26 | 2026-05-26 | Opus Genetics Inc | Behandling af presbyopi og mydriasis med fentolamin |
-
2022
- 2022-04-22 JP JP2023564598A patent/JP2024515714A/ja active Pending
- 2022-04-22 CA CA3216328A patent/CA3216328A1/en active Pending
- 2022-04-22 AU AU2022261123A patent/AU2022261123A1/en active Pending
- 2022-04-22 WO PCT/US2022/025912 patent/WO2022226286A1/en not_active Ceased
- 2022-04-22 US US18/556,599 patent/US20240216334A1/en active Pending
- 2022-04-22 CN CN202280042827.1A patent/CN117529316A/zh active Pending
- 2022-04-22 EP EP22792565.8A patent/EP4326261A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7329019B2 (ja) | 老視を治療するための組成物及び方法 | |
| JP2022505950A5 (enExample) | ||
| US5459133A (en) | Methods and products for treating presbyopia | |
| CA2672985C (en) | Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia | |
| CA3140889A1 (en) | Carbachol-brimonidine formulations to enhance anti-presbyopia effects | |
| KR20180014825A (ko) | 눈의 굴절 이상 치료 및 원거리 시력 개선용 조성물 및 방법 | |
| AU2023208076A1 (en) | Fixed dose combination of brimonidine and timolo | |
| JP2022536662A (ja) | 多焦点性を作り出すために偽水晶体患者において副交感神経刺激薬を単独でまたは１種類もしくは複数種類のαアゴニストと組み合わせて使用する方法 | |
| WO2005067891A1 (en) | Compositions comprosing memantine and polyanionic polymers for administration to the eye | |
| Kocamaz et al. | Topiramate-induced acute myopia, diplopia, and photosensitivity: a case report | |
| JP2024515714A (ja) | 散瞳、緑内障、及び他の眼の病態を治療するための方法及び組成物 | |
| KR20230098630A (ko) | 노안의 예방, 제어 및 근절에 효과적인 저농도 투여량의 상승적 안과 조성물 | |
| EP0205606A1 (en) | PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS MYDRIATIC AGENTS. | |
| Fleming et al. | Adrenergic Agonists (Sympathomimetics) | |
| HK40073252A (en) | Carbachol-brimonidine formulations to enhance anti-presbyopia effects | |
| WO2024167962A1 (en) | Alpha-2-adrenergic agonists for improving vision | |
| HK40066668A (en) | Using parasympathomimetic drugs alone or, in combination with one or more alpha agonists in pseudophakic patients, to create multi-focality | |
| CA3178254A1 (en) | Low-dose carbachol compositions and methods for treatment of night vision disturbance | |
| HK40014460B (en) | Aceclidine for use in the treatment of presbyopia |